← Browse by Condition
Medical Condition

pneumonia

Total Trials
13
Recruiting Now
13
Trial Phases
Phase 3, EARLY_Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for pneumonia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — pneumonia Clinical Trials

How many clinical trials are currently recruiting for pneumonia?
ClinicalMetric currently tracks 13 actively recruiting clinical trials for pneumonia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 13. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for pneumonia?
pneumonia research spans Phase 1 (1 trial), Phase 2 (2 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a pneumonia clinical trial?
Eligibility criteria for pneumonia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
2
Phase 3
1
Top Sponsors
Cairo University 2 trials
Helwan University 1 trial
Massachusetts General Hospital 1 trial
Assiut University 1 trial
National Institutes of Health Clinical Center (CC) 1 trial

Recruiting Clinical Trials

NCT07530146 Phase 3
Recruiting
Comparative Efficacy and Safety of Propofol-Ketamine Combination Versus Propofol Monotherapy in Geriatric Patients Under Invasive Ventilation
Enrollment
41 pts
Location
Egypt
Sponsor
Helwan University
View Trial →
NCT06950294 EARLY_Phase 1
Recruiting
iNO300 Therapy in Critically Ill Patients With Pneumonia
Enrollment
34 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT06983366
Recruiting
Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases
Enrollment
700 pts
Location
Egypt
Sponsor
Assiut University
View Trial →
NCT00077909
Recruiting
Study of Lung Proteins in Patients With Pneumonia
Enrollment
750 pts
Location
United States
Sponsor
National Institutes of Health ...
View Trial →
NCT06123650
Recruiting
Post Stroke Dysphagia: Effect of Adding rTMS to Conventional Therapy on the Prevalence of Pneumonia.
Enrollment
70 pts
Location
Egypt
Sponsor
Cairo University
View Trial →
NCT06169514
Recruiting
Health Systems and Policy Contexts of Medical Oxygen
Enrollment
1 pts
Location
Cambodia, Laos, Libe...
Sponsor
Murdoch Childrens Research Ins...
View Trial →
NCT05123755 Phase 2
Recruiting
Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.
Enrollment
120 pts
Location
United States
Sponsor
Vasomune Therapeutics, Inc.
View Trial →
NCT06506617
Recruiting
HCAPPED I: HCAP-Pcr in Emergency Department
Enrollment
93 pts
Location
Italy
Sponsor
Azienda Ospedaliero-Universita...
View Trial →
NCT06692400
Recruiting
The Effects of Endotracheal Suctioning on Pain and Serum Markers
Enrollment
110 pts
Location
United States
Sponsor
Loma Linda University
View Trial →
NCT06225258 Phase 2
Recruiting
Xanthohumol as an Adjuvant in the Treatment of Septic Shock
Enrollment
50 pts
Location
Poland
Sponsor
Medical University of Lublin
View Trial →
NCT06911658
Recruiting
Infectious Complications After Esophagectomy
Enrollment
350 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
View Trial →
NCT06835842
Recruiting
Effect of Rib Mobilization on Weaning Parameters From Mechanical Ventilator in Patients With Pneumonia
Enrollment
60 pts
Location
Egypt
Sponsor
Cairo University
View Trial →
NCT05181696
Recruiting
Retrospective Analysis of Chest X-ray Severity Scoring System of COVID-19 Pneumonia
Enrollment
200 pts
Location
Croatia
Sponsor
Osijek University Hospital
View Trial →

Related Conditions

septic shock (2) critical illness (2) sepsis (2) the critically ill patient is requiring intubation (1) copd (1) ild (1) bronchiectasis (1) pneumothorax (1) pleural effusion disorder (1) pulmonary oedema (1) pulmonary disease (1) lung disease (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology